[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-382651-105":59,"doc-detail-382651-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","transcatheter-arterial-embolization-tae-of-cancer-related-bleeding","Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding","","Approximately 10% of cancer patients experience bleeding, ranging from minor episodes to major hemorrhage. This multicenter retrospective cohort study assessed the effectiveness and safety of arterial embolization for tumor hemorrhages in patients with solid cancers. Data were collected for individuals receiving transcatheter arterial embolization (TAE) between January 2020 and May 2023. Among 92 treated patients, technical success occurred in 82 cases and clinical success in 84.8%; complications appeared in 10 patients and 30-day bleeding-related mortality was 15.2%.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transcatheter-arterial-embolization-tae-of-cancer-related-bleeding/382651/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transcatheter-arterial-embolization-tae-of-cancer-related-bleeding/382651.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What patient group and condition does this study focus on?","Question",{"text":113,"@type":114},"The study evaluates solid-cancer patients who developed tumor hemorrhages, including cancer-related bleeding episodes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What time window and study design were used?",{"text":118,"@type":114},"It is a multicenter retrospective cohort study using data from January 2020 to May 2023.",{"name":120,"@type":111,"acceptedAnswer":121},"What outcomes did the researchers report for TAE effectiveness and safety?",{"text":122,"@type":114},"Technical success was achieved in 89.1% of cases, clinical success in 84.8% with a 30-day bleeding-related mortality of 15.2%, and complications occurred in 10.9% of patients.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},382651,1790469879,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","medicina  \nArticle  \nTranscatheter Arterial Embolization (TAE) of Cancer-Related Bleeding  \nRoberto Minici 1, Giuseppe Guzzardi 2, *, Massimo Venturini 3,4, Federico Fontana 3,4, Andrea Coppola 3, Marco Spinetta 2, Filippo Piacentino 3, Armando Pingitore 1, Raffaele Serra 5, Davide Costa 6,  \nNicola Ielapi 7, Pasquale Guerriero 8,9, Biagio Apollonio 10, Rita Santoro 11, MGJR Research Team 12, Luca Brunese 9,13 and Domenico Lagan 1,14  \nCitation: Minici, R.; Guzzardi, G.; Venturini, M.; Fontana, F.; Coppola, A.; Spinetta, M.; Piacentino, F.;  \nPingitore, A.; Serra, R.; Costa, D.; et al. Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding. Medicina 2023, 59, 1323. [https://](https://)[ ](https://)[doi.org/10.3390/medicina59071323](doi.org/10.3390/medicina59071323)  \nAcademic Editor: Dimitrios Filippiadis  \nReceived: 29 May 2023  \nRevised: 17 June 2023  \nAccepted: 17 July 2023  \nPublished: 18 July 2023  \nCopyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Radiology Unit, Dulbecco University Hospital, 88100 Catanzaro, Italy; [miniciroberto@gmail.com](miniciroberto@gmail.com) (R.M.); [armando.pingitore@gmail.com](armando.pingitore@gmail.com) (A.P.); [domenico.lagana@unicz.it](domenico.lagana@unicz.it) (D.L.)  \n2 Radiology Unit, Maggiore della Carit University Hospital, 28100 Novara, Italy; [marcospinetta90@gmail.com](marcospinetta90@gmail.com)  \n3 Diagnostic and Interventional Radiology Unit, ASST Settelaghi, Insubria University, 21100 Varese, Italy; [massimo.venturini@uninsubria.it](massimo.venturini@uninsubria.it) (M.V.); [federico.fontana@uninsubria.it](federico.fontana@uninsubria.it) (F.F.); [andrea.coppola@asst-settelaghi.it](andrea.coppola@asst-settelaghi.it) (A.C.); fi[lippo.piacentino@asst-settelaghi.it](lippo.piacentino@asst-settelaghi.it) (F.P.)  \n4 School of Medicine and Surgery, Insubria University, 21100 Varese, Italy  \n5 Vascular Surgery Unit, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Dulbecco University Hospital, 88100 Catanzaro, Italy; rserra@unicz.it  \n6 Department of Law, Economics and Sociology, Magna Graecia University of Catanzaro,  \n88100 Catanzaro, Italy; [davide.costa@unicz.it](davide.costa@unicz.it)  \n7 Department of Public Health and Infectious Disease, Sapienza University of Rome, 00185 Rome, Italy; [nicola.ielapi@uniroma1.it](nicola.ielapi@uniroma1.it)  \n8 Radiology Unit, Santobono-Pausilipon Hospital, 80129 Naples, Italy; [pasqualeguerriero@gmail.com](pasqualeguerriero@gmail.com)  \n9 Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy; [luca.brunese@unimol.it](luca.brunese@unimol.it)  \n10 Radiology Unit, San Timoteo Hospital, 86039 Termoli, Italy; [bapollonio@sirm.org](bapollonio@sirm.org)  \n11 Haemophilia and Thrombosis Center, Dulbecco University Hospital, 88100 Catanzaro, Italy; [ritacarlottasantoro@gmail.com](ritacarlottasantoro@gmail.com)  \n12 Magna Graecia Junior Radiologists Research Team, 88100 Catanzaro, Italy; [radiologyumg@gmail.com](radiologyumg@gmail.com)  \n13 Scientific Committee of the Italian National Institute of Health (Istituto Superiore di Sanit , ISS),  \n00161 Rome, Italy  \n14 Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro,  \n88100 Catanzaro, Italy  \n* Correspondence: [giuguzzardi@gmail.com](giuguzzardi@gmail.com)  \nAbstract: Background and Objectives: Roughly 10% of cancer patients experience an episode of bleeding. The bleeding severity can range from occasional trivial bleeds to major bleeding. The treatment for the bleeding may vary, depending on the clinical condition and anatomical site, and may include various strategies, among which TAE ","cbCaiuEgEwgTXtfG","https://ap.wps.com/l/cbCaiuEgEwgTXtfG","pdf",6513216,17,"English","# Abstract\n## Background and Objectives\n## Materials and Methods\n## Results\n## Conclusions","[{\"question\":\"What patient group and condition does this study focus on?\",\"answer\":\"The study evaluates solid-cancer patients who developed tumor hemorrhages, including cancer-related bleeding episodes.\"},{\"question\":\"What time window and study design were used?\",\"answer\":\"It is a multicenter retrospective cohort study using data from January 2020 to May 2023.\"},{\"question\":\"What outcomes did the researchers report for TAE effectiveness and safety?\",\"answer\":\"Technical success was achieved in 89.1% of cases, clinical success in 84.8% with a 30-day bleeding-related mortality of 15.2%, and complications occurred in 10.9% of patients.\"}]","Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding | PDF",1790251512,43]